Publication | Open Access
OP0021 Efficacy and safety results of a phase iii study comparing fkb327, an adalimumab biosimilar, with the adalimumab reference product in patients with active rheumatoid arthritis
10
Citations
0
References
2017
Year
No additional data available for this publication yet. Check back later!